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In Haemophilus influenzae Rd KW20, we identified a gene, adhC, which encodes a class III alcohol dehydro-
genase (AdhC) and has S-nitrosoglutathione reductase activity. adhC exists on an operon with estD, which
encodes an esterase. Divergent to the adhC-estD operon is the Haemophilus influenzae nmlR gene (nmlRHI),
which encodes a MerR family regulator that is homologous to the Neisseria MerR-like regulator (NmlR).
Analysis of an nmlRHI mutant indicated that expression of the adhC-estD operon is regulated by NmlRHI in
strain Rd KW20. Chromosomal inactivation of either adhC or nmlRHI resulted in sensitivity to S-nitrosoglu-
tathione and decreased S-nitrosoglutathione reductase activity. Examination of the NmlRHI-AdhC system in
the genome sequences of nontypeable H. influenzae strains R2846, R2866, and 86-028NP identified significant
variations. The adhC gene of 86-028NP was predicted to be nonfunctional due to a premature stop codon.
Polymorphisms in the operator/promoter region of R2866 resulted in reduced enzyme activity. This correlated
with an increased sensitivity to S-nitrosoglutathione. The adhC-nmlRHI system was examined in thirty-three
clinical isolates (both capsular and nontypeable strains). Nucleic acid sequence data showed that only strain
86-028NP contained a premature stop codon. There were some variations in the DNA sequence of the
operator/promoter region which altered the nmlRHI promoter. However, the clinical isolates still possessed
S-nitrosoglutathione reductase activity and showed at least the equivalent ability to grow in the presence of
S-nitrosoglutathione as Rd KW20. These data suggest that the nmlRHI-adhC system has a role in the defense
against nitrosative stress in Haemophilus influenzae.
Haemophilus influenzae is an obligate human parasite (25).
This bacterium is able to survive in the human nasopharynx as
a harmless commensal and is present in the upper respiratory
tracts of up to 80% of healthy individuals (40). H. influenzae
does possess the ability to move to other sites within the body,
resulting in a variety of diseases. Isolates of H. influenzae can
be subdivided into encapsulated or nonencapsulated strains.
The latter are defined by their failure to agglutinate with an-
tisera against the recognized H. influenzae capsular polysac-
charides and are referred to as nontypeable H. influenzae
(NTHi). Encapsulated and nonencapsulated strains have sim-
ilar morphological and metabolic properties, but they manifest
differently in a clinical context (32). NTHi is a common cause
of otitis media, sinusitis, and conjunctivitis (37), as well as
chronic bronchitis, and is an important cause of community-
acquired pneumonia. In the transition from colonization to
cause of these pathologies, the organism must overcome innate
immunity.
The innate immune response produces reactive oxygen spe-
cies (ROS) and reactive nitrogen species (RNS). ROS, which
include a superoxide anion (O2
·), hydrogen peroxide (H2O2),
and a hydroxyl radical (HO·), cause damage to proteins, nu-
cleic acids, and cell membranes (24, 38).
Nitric oxide (NO), produced by inducible nitric oxide syn-
thase (iNOS), is recognized as an important mediator of the
innate immune response to infection (10). NO interacts with
biomolecules within its immediate environment to form other
RNS, such as S-nitrosoglutathione (GSNO) and nitrosothiols
through interactions with glutathione (GSH) and thiols, re-
spectively. RNS possess antimicrobial activity through their
interaction with numerous targets within the bacterial cell. NO
and S-nitrosothiols can inhibit bacterial DNA replication via
the release of zinc from metalloproteins (35). NO also inhibits
bacterial respiration (29, 36). By inhibiting ribonucleotide re-
ductase, RNS limit the availability of precursors for synthesis
and repair of DNA (21). There is also evidence that Fe-S
clusters of some proteins are targets for RNS.
In humans and animal model systems, it has been shown that
there are increased levels of iNOS expression and NO produc-
tion upon microbial infection (12, 28). In the case of otitis
media, it is the middle ear epithelium that responds to invading
pathogens, such as Streptococcus pneumoniae and H. influen-
zae, by releasing proinflammatory cytokines and other media-
tors, a process that might facilitate invasion (27, 34, 39). In
experiments with ear effusions from patients, it has been shown
that middle ear infections result in the induction of expression
of iNOS (23) and that the resulting NO production has a role
in bacterial killing in this environment. If iNOS was inhibited,
there was little NO present, and a decrease in bacterial killing
was observed (28). RNS defense mechanisms have been de-
scribed for the enteric pathogen Salmonella enterica serovar
Typhimurium. This bacterium possesses a number of en-
zymes with the ability to metabolize RNS. The flavohemo-
globin Hmp, the flavorubredoxin NorV, and the nitrite re-
ductase Nrf all have the ability to reduce NO, and the class
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III alcohol dehydrogenase (AdhC) has been shown to re-
duce GSNO (10, 22). In S. enterica serovar Typhimurium, it
has been shown that Hmp plays the principle role in defense
against NO, and the hmp mutant is avirulent in a mouse model
system (1). AdhC from Escherichia coli has been shown to use
GSNO as a substrate (22), but AdhC was not essential for viru-
lence in S. enterica serovar Typhimurium (1).
Recently, we described a MerR-like regulator in Neisseria
gonorrhoeae which we called Neisseria MerR-like Regulator
(NmlR). We have established that NmlR regulates its own
expression and that of a divergently transcribed gene, adhC
(18). The adhC gene encodes a class III alcohol dehydrogenase
that, in different systems, is known to possess NADH-GSNO
oxidoreductase activity (22). A survey of bacterial genome
sequences identified NmlR homologs in numerous bacteria,
including several pathogens. NmlR forms a subfamily of
the MerR family, which includes a member in H. influenzae,
NmlRHI. Here we describe experiments to investigate the reg-
ulation of adhC by NmlRHI and the function of AdhC in
defense against nitrosative stress. The organization and func-
tion of this system were also compared in a collection of en-
capsulated and NTHi strains.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Thirty-three H. influenzae strains
were used in this study. These strains included isolates from the Finnish otitis
media collection as used in previous studies (3, 6, 16, 26) and encapsulated
clinical isolates from the A. Smith laboratory (9). Brain heart infusion (BHI)
medium was prepared with 3.7% (wt/vol) BHI Powder (Oxoid). For solid me-
dium, 1.5% agar powder was added. Medium was sterilized by autoclaving at
121°C for 20 min. Levinthal blood (10% [wt/vol]) was added for solid medium.
BHI broth required NAD (2 g/ml) and 10 l/ml hemin solution (0.1% [wt/vol]
hemin, 0.1% [wt/vol] L-histidine, 4% [vol/vol] triethanolamine). M-IV compe-
tence medium was prepared as described by Herriott et al. (14). Solutions for
media were sterilized individually, either by filter sterilizing or by autoclaving.
The solutions were mixed under sterile conditions. Chemically defined medium
(CDM) was prepared as described by Coleman et al. (7). The final pH of CDM
was adjusted to 7.56 by NaHCO3. CDM was sterilized by filter sterilization
through a 0.22-m filter.
Chromosomal inactivation of adhC and nmlRHI. A 1.3-kb DNA fragment
containing nmlRHI and flanking DNA sequences was amplified by PCR from H.
influenzae using the following primers: HI0186KOF (5-ACTCACATTCGCCA
CATTCA-3) and HI0186KOR (5-CACGGATTAAGCCTGTTCCT-3). A 2.0-kb
DNA fragment containing adhC and flanking DNA sequences was amplified by
PCR from H. influenzae using the following primers: HI0185KOF (5-CAGTG
CCAATACCAATGCAC-3) and HI0185KOR (5-CGTTTTAATTCGGCAAT
TTGA-3). PCR was carried out at 96°C for 10 min, then 30 cycles of 96°C for
30 s, 55°C for 30 s, and 72°C for 3 min, followed by a final extension step of 72°C
for 10 min. PCR products were purified (using a QIAquick PCR purification kit)
and cloned into pGEM-T Easy Vector (Promega), creating the plasmids
pGEM-T::nmlRHI-ko and pGEM-T::adhC-ko. These plasmids were digested with
BsaBI and FalI (New England Biolabs), respectively (Fig. 1), and treated with
calf intestinal alkaline phosphatase. The kanamycin-resistant gene cassette from
pUC4Kan was isolated by digestion with HincII and extracted from a 1% agarose
gel by using a QIAquick gel extraction kit (QIAGEN). This cassette has no
promoter or terminator and does not effect transcription or create a polar effect.
The kanamycin-resistant cassette was phosphorylated and cloned into the di-
gested clones pGEM-T::nmlRHI-ko and pGEM-T::adhC-ko. The orientation of
the insert was identified, and plasmids containing the kanamycin resistance open
reading frame (ORF) in the same orientation as the genes were selected. The
resulting plasmids, pGEM-T::nmlRHI-ko::kan and pGEM-T::adhC-ko::kan, were
linearized with NdeI and Sau96I, respectively, before being transformed into H.
influenzae Rd KW20. Transformation into H. influenzae was performed as de-
scribed by Herriott et al. (14). Competent H. influenzae was incubated with
linearized DNA at 37°C for 30 min. Mutants were created by double crossover,
and recombinant colonies were selected on BHI plates with 20 g/ml kanamycin.
Site-specific recombination of adhC::Kanr into the chromosome was con-
firmed by PCR amplification with HIadhCkOF-F (5-AAAGGCTTTTTCTCCCC
AAG-3) and HIadhCkOF-R (5-CAAACGTTTCGGGCCTAATA-3). These
primers are located outside the sites used for generating the original construct.
Site-specific recombination of nmlRHI::Kanr was confirmed by PCR using a
primer within the kanamycin resistance cassette Kan-F (5-CGAGGCGGCGA
TTAAATTCC-3) and a primer located on the H. influenzae chromosome and
outside the sites used to generate the original construct, HInmlRko-scr (5-CA
CGATCTTCCCCTAAATAG-3).
A chromosomal preparation from the H. influenzae adhC gene was sheared by
repeatedly passing it through a needle (23 gauge by 1.5 inches; Terumo Corp.).
The sheared product was transformed into clinical isolates of H. influenzae.
Site-specific recombination of adhC::Kanr into the chromosome was confirmed
FIG. 1. Organization of the nmlRHI and adhC gene cluster of H. influenzae. The DNA sequence for the intergenic spacer region of adhC-estD
(HI0185 and HI0184) to nmlRHI (HI0186) is shown. The 10 and 35 promoter elements for PnmlRHI are boxed and annotated 10 nmlRHI and
35 nmlRHI; for PadhC, they are underlined and annotated 10 adhC and  35 adhC. The dyad symmetry is indicated with arrows. The start of
translation is in bold type.
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by PCR amplification with HIadhCkOF-F (5-AAAGGCTTTTTCTCCCCAA
G-3) and HIadhCkOF-R (5-CAAACGTTTCGGGCCTAATA-3).
Reverse transcriptase PCR. RNA was extracted from H. influenzae Rd KW20
and H. influenzae nmlRHI strains by using a QIAGEN RNeasy minikit. RNA was
quantified using an A260 reading. RNA was checked for DNA contamination by
PCR, and no product was detected. Prior to the reverse transcriptase (RT)
reaction, RNA was further treated to remove any residual DNA by using Pro-
mega DNase (Promega). The RT reaction was performed using a QIAGEN
Omniscript reverse transcriptase kit. Following the RT reaction, a multiplex PCR
was performed with primers for the 16S rRNA gene (16SFOR, 5-AGTCCAC
GCCCTAAACGATGT-3; 16SREV, 5-TACTCCCCAGGCGGTCAAT-3)
and primers from estD (E1, 5-CCCAAGGCTGCTCGGTC-3) to adhC (A1,
5-TTCAACGCGTCCGTTCCAA-3). PCR was carried out with New England
Biolabs Taq polymerase using an initial 96°C for 10 min followed by 30 cycles of
96°C for 45 s, 54°C for 45 s, and 72°C for 30 s and a final elongation step of 72°C
for 10 min.
Growth assays. Growth assays were performed with H. influenzae strains using
CDM. Cells were grown overnight in 5 ml of CDM and, prior to the assay, were
measured at an optical density of 600 nm (OD600; Hitachi U-3000 spectropho-
tometer) to standardize the amount of cells inoculated. From the overnight
culture, 1 ml was inoculated into 50 ml of CDM in a 250-ml conical flask.
Different specific concentrations of stress agent were added to the medium.
Cultures were incubated aerobically at 37°C with shaking at 190 rpm. OD600
measurements were taken at different time points for 10 h. The assays were done
in triplicate. Assay results were represented as growth curves over this period or,
for clarity for the large set of clinical isolates, as percentages of survival at this
time point.
GSNO reductase enzyme assays. NADH-dependent GSNO reductase activity
was measured as previously described (22). Fresh overnight cultures of H. influ-
enzae were inoculated into 100 ml of CDM in 500-ml conical flasks and grown
aerobically at 37°C with shaking at 190 rpm until an OD600 measurement be-
tween 0.4 and 0.7 was obtained. The cells were harvested (5,000  g at 4°C for
10 min) and washed twice with 0.1 M phosphate buffer (pH 7.0) before resus-
pension in 2 ml of phosphate buffer. The suspension was frozen at 80°C,
thawed at room temperature, given a brief vortexing, and frozen again at 80°C.
This freeze-thaw process was performed four more times before the cells were
centrifuged at 13,000  g at 4°C for 15 min. The final supernatant (cell extract)
was used for assays. The total protein concentration of the supernatant was
determined spectrophotometrically using the formula protein (mg/ml)  1.55 
A2800.76  A260 (19). GSNO reductase activity was expressed as mol of
NADH oxidized per minute per mg of total protein. The assays were done in
triplicate.
PCR-based sequence analysis of clinical isolates of H. influenzae. PCR using
primers HIadhCko-scr and HInmlRko-scr was used to generate a DNA fragment
covering the adhC-nmlRHI region of 33 clinical isolates of H. influenzae. PCR was
carried out using Vent polymerase (New England Biolabs) and the following
conditions: 96°C for 10 min and then 30 cycles of 96°C for 30 s, 55°C for 30 s, and
72°C for 3 min, followed by a final extension step of 72°C for 10 min. PCR
products were sequenced using a BigDye Terminator v3.1 sequencing kit (Ap-
plied Biosystems).
Nucleotide sequence accession numbers. The nucleotide sequences have been
submitted to GenBank under accession numbers EF523999 to EF524031.
RESULTS
H. influenzae possesses an NmlR-like transcription factor. A
survey of the H. influenzae Rd KW20 genome sequence (11)
showed that H. influenzae contained an NmlR homolog that we
have named NmlRHI (HI0186; genome location, 200733 to
201140). NmlRHI shows high identity (93%) to the NmlR from
N. gonorrhoeae (18). As in the nmlR system of N. gonorrhoeae,
the nmlRHI gene is adjacent to a putative operon transcribed
from the opposite DNA strand that is composed of two genes
annotated as adhC and estD, which encode a class III alcohol
dehydrogenase and an esterase, respectively. The promoters
for the nmlRHI and adhC-estD cistrons are overlapping and
divergent, with a dyad symmetry (the NmlRHI binding site),
located between the promoter elements for adhC-estD (Fig. 1).
This is consistent with the arrangement for the prototype for
the MerR family, merR-merTPAD, and is present in other MerR
family regulators (4). The predicted 10 (5/6 identity to the
consensus sequence) and35 (4/6) elements for the promoter for
nmlRHI are separated by 18 bp. The operator/promoter for
PadhC fulfils the criteria for a MerR operator/promoter (4).
The promoter elements for adhC (10 with 4/6 and 35 with
3/6 identity to the consensus sequence) are separated by a
nonoptimal spacer region of 19 bp. Overlapping with the 35
element and extending within the PadhC spacer is a 9-2-9 dyad
symmetry.
NmlRHI regulates the adhC-estD operon. We have already
established that in N. gonorrhoeae, NmlR regulates the expres-
sion of the adhC-estD operon (18). Using primers from within
the estD and adhC genes of H. influenzae, we first performed
RT-PCR. This generated a 560-bp product, which was the
expected size if the mRNA derived from adhC and estD was
contiguous (Fig. 2A, lane 2). RT-PCR was then performed
using RNA extracted from the H. influenzae wild type and the
nmlRHI mutant and, using known RNA concentrations for the
RT reaction and a multiplex PCR with a 16S rRNA gene as a
standard, the yields of the 560-bp adhC-estD RT-PCR products
were compared. Figure 2 shows that there was significantly
more of the adhC-estD RT-PCR product from H. influenzae
(Fig. 2A, lane 2) than from the nmlRHI mutant (Fig. 2A, lane
1). Thus, we concluded that the adhC-estD genes form an
operon that requires NmlRHI for maximal expression.
In silico promoter analysis. Promoters within the adhC-
nmlR intergenic spacer regions of the NmlR subfamily from a
number of bacteria were identified using BPROM software
available from Softberry (Mount Kisco, NY). The predicted
binding sites for the NmlRHI subfamily were then identified
and aligned (Fig. 2B). From this alignment, a consensus bind-
ing site for NmlRHI transcription factors was formulated using
WebLogo (http://weblogo.berkeley.edu/logo.cgi) (Fig. 2C).
This was used to search the whole-genome sequence of H.
influenzae Rd KW20, using both PRODORIC, release 2, Vir-
tual Fooprint Web-based facility (http://prodoric.tu-bs.de/),
and Predict Regulon Server software (41). Both of these pro-
grams resulted in the sole identification of the promoter region
for HI0185 (adhC). The next best scores were investigated as
possible binding sites with lower identity to the consensus
sequence, but none contained a dyad symmetry or was located
in the promoter elements. Taken together, these data suggest
that NmlRHI is a specific regulator of the adhC-estD operon
and does not act as a global regulator of gene expression.
H. influenzae Rd KW20 AdhC exhibits NADH-dependent
GSNO reductase activity. Class III alcohol dehydrogenases
have been shown to catalyze the reduction of GSNO using
NADH as an electron donor (22). We tested whether this
activity was also associated with AdhC in H. influenzae by
determining NADH-GSNO oxidoreductase activity in cell ex-
tracts. Figure 3A shows that the rate of GSNO-dependent
oxidation of NADH in the nmlRHI mutant was more than
10-fold lower than in wild-type cells. In the adhC mutant strain,
most of the GSNO reductase activity was reduced compared to
that of both the nmlRHI mutant and the wild type. This indi-
cates that AdhC is responsible for the NADH-dependent
GSNO reductase activity in H. influenzae.
H. influenzae Rd KW20 genes adhC and nmlRHI are required
for defense against GSNO. Following the confirmation that
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AdhC catalyzed the removal of GSNO, we tested whether
adhC and nmlRHI were of significance for defense against
nitrosative stress in H. influenzae. Figure 3B shows a series of
growth curves in which wild-type and mutant strains were chal-
lenged with GSNO. For the wild-type H. influenzae strain, the
presence of 0.5 mM GSNO restricted growth during the first
4 h. However, after this time point, the growth rate increased,
and cells reached a density that was close to that seen for
FIG. 2. Regulation of the adhC-estD operon. (A) Analysis of transcription of adhC-estD using RT-PCR. Template RNA from H. influenzae Rd
KW20 (lane 2) and H. influenzae nmlRHI (lane 1). RNA size marker (lane 3) and the PCR product using genomic DNA (lane 4). (B) Consensus
NmlR binding site. The binding sites as determined by in silico analysis for H. influenzae strains are as follows: Rd KW20 (Hi RdKW20) (GenBank
accession number L42023; nucleotide coordinates 200673–200692), R2846 (accession number AADO0000000; coordinates 86235–86258), R2866
(accession number AADP0000000; coordinates 46407–46387), 86-028NP (accession number CP000057; coordinates 261657–261638), Lactobacillus
plantarum (Lac.plant) (accession number CR377164; coordinates 2681213–2681231), Enterococcus faecium (En.faec) (accession number
AAAK00000000; coordinates 9495–9515), Clostridium acetobutylicum (Cl.aceto) (accession number AE001437.1; coordinates 113616–113636),
Oceanobacillus iheyensis (Oc.ihey) (accession number BA000028; coordinates 841653–841673), Streptococcus pneumoniae (Str.pn) (accession
number AE008532; coordinates 9226–9245), Streptococcus agalactiae (Str.aga) (accession number AE0014211; coordinates 10838–10861), and
Neisseria meningitidis (NMA) (accession number AL162756.2; coordinates 80451–80471), as well as the two proven binding sites by genetic studies
for NmlR in N. gonorrhoeae PadhC (Ng PadhC) and PcopA (Ng PcopA) (18). The dyad symmetries are underlined. (C) WebLogo consensus sequence
for the binding site for NmlR.
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wild-type cells in the absence of the GSNO. In contrast, the
presence of 0.5 mM GSNO abolished growth of the adhC and
nmlRHI strains. We also tested an estD strain for GSNO re-
ductase activity and its ability to grow in the presence of
GSNO. It grew with the same profile as the wild type and
possessed similar levels of GSNO reductase activity, indicating
that the phenotype of the adhC strain is not due to effects on
estD expression (S. P. Kidd, M. P. Jennings, and A. G. McEwan,
unpublished data). Interestingly, even in the absence of nitro-
sative stress, the adhC and nmlRHI mutants grew slower than
the wild-type H. influenzae strain (Fig. 3B.).
The genome sequences of NTHi harbor the adhC-nmlRHI
system. Initial in silico analysis identified the nmlRHI-adhC
system within various strains of H. influenzae, including the
NTHi strains R2866, R2846, and 86-028NP. When these
strains of H. influenzae were analyzed, their systems showed
considerable identity to the system in strain Rd KW20, with
some exceptions. In strain 86-028NP, adhC has been annotated
as a pseudogene. It contains a mutation that results in a pre-
mature stop codon terminating the protein at amino acid 109,
suggesting that this strain might not make a functional AdhC.
There were also polymorphisms observed in the adhC-nmlRHI
intergenic spacer region, including an impaired dyad symmetry
and 10 and 35 promoter elements in strain R2866. These
differences between the nontypeable genome strains and our pre-
vious observation that adhC of N. gonorrhoeae is a pseudogene
(31) suggested the possibility that the role in defense against
GSNO demonstrated in strain Rd KW20 (as described above)
may not be representative of H. influenzae clinical isolates.
Clinical isolates of H. influenzae have a functional adhC gene
as part of their GSNO defense mechanisms. A collection of 33
clinical isolates of H. influenzae was used to measure the ac-
tivity and genetic variation of the adhC-nmlRHI system. A
region covering the adhC and nmlRHI genes and intergenic
spacer region was sequenced and aligned. The adhC gene of
strain 86-028NP has a premature stop codon. No other strain
contained this mutation. There were some variations in the
operator/promoter region of the different strains. Many strains
(NTHi strains 1247, 1207, 1181, 1124, 723, and 667 and cap-
sular strains R539, R540, R543, R546, R1831, R3368, R3230,
R874, and RM7004 and the Eagan strain) included a mutation
which resulted in an altered 10 element (less optimal, 4/6 con-
sensus, and shortened spacer region) for the PnmlRHI compared to
that of the Rd KW20 strain. Strain R2866 had a shortened dyad
symmetry, and strain 176 (an NTHi strain) had a mutation which
interrupted the dyad symmetry.
Enzyme assays were performed using representative strains
of each of the variations, as well as clinical isolates of both
NTHi and capsular strains, which were identical to Rd KW20
(strains 981, 447, R541, and R3327). Strain 86-028NP had very
low GSNO reductase activity, close to 10-fold less than that of
Rd KW20, consistent with the prediction that adhC from 86-
028NP is a nonfunctional gene (Fig. 4). Strain R2866 also
exhibited very low GSNO reductase activity, presumably as a
result of a nonoptimal operator/promoter region (as noted
above). Although there was some variation in the activities of
GSNO reductase in the other strains tested, the majority of
strains had activity levels similar to that of Rd KW20. The
exceptions were strain 176, which had twofold higher activity
than Rd KW20, and strain 723, which had an activity level that
was lower than that of Rd KW20 but higher than those of
86-028NP and R2866.
In order to assess whether there was any correlation between
GSNO reductase activity and defense against nitrosative stress,
we measured the ability of each strain to survive a GSNO
challenge. Figure 4 shows that the three strains with the lowest
GSNO reductase activities exhibited a low percentage of sur-
vival in comparison to that of strain Rd KW20 and the other
strains with high GSNO reductase activity. The correlation
between GSNO reductase activity and survival against nitrosa-
tive stress was not as clear in strain R541 or R3327 (Fig. 4).
Chromosomal inactivation of adhC from representative strains
of the clinical strains R539, R874, and 667 resulted in a signif-
icant reduction of GSNO reductase activity (data not shown).
DISCUSSION
Class III alcohol dehydrogenases are pyridine nucleotide-
dependent enzymes that catalyze the transformation of ad-
ducts of glutathione such as hydroxymethylglutathione or
GSNO. The GSNO-metabolizing activity of GSH-dependent
alcohol dehydrogenases has been known for some time (17),
but it was Liu and coworkers who recognized the widespread
distribution of this enzyme in both the eukaryotic and the
prokaryotic world and proposed that GSNO reductase activity
of this enzyme is physiologically relevant (22). Although the
phenotype of an adhC mutant in S. enterica serovar Typhi-
FIG. 3. Roles for H. influenzae, H. influenzae adhC, and H. influ-
enzae nmlRHI in GSNO metabolism. (A) S-Nitrosoglutathione reduc-
tase activities of H. influenzae strains Rd KW20 wild type (Rd), Rd
KW20 adhC (Rd adhC), and Rd KW20 nmlRHI (Rd nmlR). Y-axis
error bars indicate 1 standard deviation of the mean. Each assay
experiment was conducted in triplicate and repeated with separated
bacterial cultures for both strains. (B) Effect of GSNO on H. influen-
zae, H. influenzae adhC, and H. influenzae nmlRHI. Wild-type strain Rd
KW20 was grown in CDM (}) as were Rd KW20 adhC (X) and Rd
KW20 nmlRHI (Œ). Results are shown alongside results for each strain
grown in the presence of 0.5 mM GSNO, shown as dotted lines (Rd
KW20 [f] Rd KW20 adhC [F] and Rd KW20 nmlRHI [X]. Y-error bars
indicate 1 standard deviation of the mean. Experiments were con-
ducted in triplicate.
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murium has not been described in detail, it is known that adhC
is not required for systemic virulence of S. enterica serovar
Typhimurium in a mouse model system (1). This may mean
that adhC is not involved in defense against NO in S. enterica
serovar Typhimurium or that there is redundancy in NO de-
fense systems, consistent with the presence of a number of
enzymes involved in protection against NO. While mechanisms
for defense against ROS by H. influenzae have been described
previously (40), H. influenzae does not possess all of the en-
zymes that have been shown to be involved in NO protection
from S. enterica serovar Typhimurium. It does possess AdhC.
Like AdhC from eukaryotic and bacterial sources, the H. in-
fluenzae enzyme is able to reduce GSNO. However, for the first
time, the results presented in this report suggest that this activity
is physiologically relevant, acting as a key enzyme in defense
against RNS. Our observation that the adhC mutant was sensitive
to nitrosative stress is strong evidence that AdhC has a role in
defense against RNS killing in H. influenzae. The present result
and our recent observation that adhC-nmlR is required for sys-
temic virulence in S. pneumoniae (38a) suggest that this is an
important system for defense against nitrosative stress in nonen-
teric mucosal pathogens.
Class III alcohol dehydrogenases have been characterized in
a number of bacteria, including Rhodobacter sphaeroides and
Paracoccus denitrificans (2, 33). Both of these bacteria are
facultative methylotrophs; thus, it is essential that they are able
to defend against toxic formaldehyde. In these bacteria, there
is clear evidence that the AdhC functions as an NAD-depen-
dent dehydrogenase that oxidizes hydroxymethylglutathione
(formed from the reaction of formaldehyde and GSH). A mu-
tant lacking adhC in R. sphaeroides was highly sensitive to
killing by methanol, indicative of an inability to remove form-
aldehyde. In E. coli, the expression of adhC is controlled by the
FrmR transcriptional repressor that has been shown to re-
spond to formaldehyde but not to GSNO (13). Inspection of
the genomic organization of the adhC gene cluster in S. en-
terica serovar Typhimurium suggests a similar pattern of reg-
ulation, although no analysis of gene expression has been re-
ported. In the case of R. sphaeroides, the expression of adhC in
response to formaldehyde is positively and negatively regu-
lated by two sensor histidine kinase-response regulator two-
component systems (15). These data support the conclusion
that in enteric bacteria and in facultative methylotrophs, the
expression of adhC is associated with defense against aldehyde
stress. There were no differences in sensitivity to formaldehyde
between the H. influenzae strain Rd KW20 and the adhC strain
(data not shown).
A key difference between the adhC system in H. influenzae
and that in E. coli appears to be in regulation of their expres-
sion. In H. influenzae, there is no FrmR repressor, and the
complex sensor histidine kinase-response regulator system that
regulates expression of adhI in response to methanol/formal-
dehyde in R. sphaeroides also appears to be absent. Instead,
regulation is via NmlRHI, and the nmlR-adhC gene pair is
found in a number of bacteria, including N. gonorrhoeae, for
which it was first described (18). In the pathogen Neisseria,
NmlR is the sole MerR-like regulator, and there are three
regulatory targets, adhC, trxB, and copA (18). In contrast, H.
influenzae harbors three MerR-like regulators. Analysis of the
binding sites for NmlR homologs from the bacteria which
harbor an nmlR-adhC pair has identified a significant degree of
identity between the dyad symmetries of these predicted bind-
ing sites, and a consensus sequence has been formulated (Fig.
2). Our analysis predicts NmlRHI has only one target within the
FIG. 4. Effect of GSNO on clinical isolates of H. influenzae. S-Nitrosoglutathione reductase activities of H. influenzae strains are shown with
filled bars. Y-error bars indicate 1 standard deviation of the mean. Each enzyme assay experiment was conducted in triplicate and repeated with
separated bacterial cultures for both strains. The sensitivities of clinical isolates of H. influenzae to GSNO are shown with open bars. Separate
cultures were grown in CDM and CDM with 0.5 mM GSNO. The growth was followed over 18 h, and the results are presented as the percentages
of CFU/ml in 0.5 mM GSNO relative to that of CDM alone. Y-error bars indicate 1 standard deviation of the mean. Each assay experiment was
conducted in triplicate.
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H. influenzae genome, the divergent adhC gene (Fig. 1). The
NmlRHI-AdhC system is distinctive from the previously pub-
lished NmlR system of N. gonorrhoeae, not only in its regulon
but also because, as we have recently reported for N. gonor-
rhoeae, the adhC is nonfunctional (31). Together with the dif-
ference in the genes that NmlR and NmlRHI regulate, these
distinctive features may indicate differences in the signal to
which these NmlR regulators respond. We have not yet iden-
tified the stress signal to which NmlRHI responds. The tran-
scription factor contains two cysteine residues that are con-
served in all proteins of the NmlR subfamily, except for those
in streptococci (Stroeher et al., submitted). It is tempting to
suggest that the activation of NmlRHI may involve oxidation of
these cysteine residues, as observed for a number of other
transcription factors (30). The trigger for this may be disulfide
stress, although this needs to be tested in future experiments.
It is also possible, considering the role for GSNO, that the
cysteine residues are nitrosalated and that this is acting as the
switch to an activator form for NmlRHI.
Analysis of adhC from the genome sequences of nontype-
able strains 86-028NP, R2846, and R2866 indicated variations
that might result in nonfunctional AdhC (strain 86-028NP) or
reduction of adhC expression (strain R2866). This casts doubt
on the importance of adhC in GSNO defense as a general
mechanism in H. influenzae. Assays of AdhC expression and
GSNO defense in a set of 33 clinical isolates confirmed that
these genome strains were atypical, with all other strains ex-
pressing high levels of AdhC activity that correlated well with
GSNO defense. Chromosomal inactivation of adhC from a
selection of these clinical strains resulted in a significant loss of
GSNO reductase activity.
Our study suggests that the adhC-nmlRHI system may be
important for virulence in H. influenzae. NO is recognized as a
key component of the innate immune response to bacterial
pathogens, particularly the niches inhabited by H. influenzae.
Specifically with the ear, nose, and throat, different studies
have shown that NO is produced in response to infection and
that NO functions in restricting the spread of bacteria from this
niche (20). Also, relevant studies have shown the survival of H.
influenzae in macrophage lines and adenoid tissues and have
identified NO production and the antimicrobial functions of
NO in otitis media (8, 20, 23, 25, 27). A study which used H.
influenzae to examine bacterial meningitis in rats has shown
that NO was important in increasing the blood-brain barrier
permeability, although it did not investigate the antimicrobial
activity of NO (5). Implicit in these results but not elaborated
is that while increasing NO levels have a role in bacterial
passage from the blood to the brain, maybe through altering
cerebral blood flow or brain edema or other consequences of
subarachnoid space inflammation, the bacteria need to be able
to defend against the levels of NO being produced. Our studies
identify the adhC-nmlRHI system as the major mechanism in
H. influenzae for defense against GSNO, a stress which is
physiologically relevant in a host environment producing NO,
and show that this system is functional in most clinical isolates.
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